The U.S. Drug Enforcement Administration (DEA) has announced its intention to place 5 tryptamine hallucinogens in schedule I of the Controlled Substances Act, noting that they “share structural and pharmacological similarities with several schedule I tryptamine hallucinogens” including DMT and psilocyn. The five tryptamines are as follows: 4-Hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT)…


Previous articleHorizons: Grounds for Collective Effervescence
Next articleBeckley Psytech Announces First Cohort of Psychotherapists Have Begun Training for Treatment Resistant Depression Phase 2 Trials